We report 2 patients with multicentric Castleman disease. Both presented with multiple, indurated, hyperpigmented plaques, generalized lymphadenopathy and polyclonal hypergammaglobulinemia. Biopsy specimens showed infiltration of mature plasma cells and lymphocytes in the dermis and lymph nodes. Skin specimens were negative for human herpesvirus 8, latent nuclear antigen 1 and Epstein-Barr virus by in situ hybridization. PCR disclosed clonal T-cell receptor gene rearrangement in the bone marrow cells of 1 patient. We discuss the possible relationship between multicentric Castleman disease and systemic plasmacytosis as well as plasma cell proliferation.

Keywords:
Multicentric Castleman disease, Lymphoma, Systemic plasmacytosis
1.
Castleman B, Iverson L, Menendez VP: Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956;9:822–830.
2.
Keller AR, Hochholzer L, Castleman B: Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670–683.
3.
Gaba AR, Stein RS, Sweet DL, Variakojis D: Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978;69:86–90.
4.
McClain KL, Natkunam Y, Swerdlow SH: Atypical cellular disorders. Hematology Am Soc Hematol Educ Program 2004:283–296.
5.
Frizzera G: Castleman’s disease and related disorders. Semin Diagn Pathol 1988;5:346–364.
6.
Kessler E: Multicentric giant lymph node hyperplasia: a report of seven cases. Cancer 1985;56:2446–2451.
7.
Watanabe S, Ohara K, Kukita A, Mori S: Systemic plasmacytosis. Arch Dermatol 1986;122:1314–1320.
8.
Kodama A, Tani M, Hori K, Tozuka T, Matsui T, Ito M, Nakao S, Fujita T, Kobayashi H: Systemic and cutaneous plasmacytosis with multiple skin lesions and polyclonal hypergammaglobulinaemia: significant serum interleukin-6 levels. Br J Dermatol 1992;127:49–53.
9.
Salvi M, Girasole G, Pedrazzoni M, Passeri M, Giuliani N, Minelli R, Braverman LE, Roti E: Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves’ disease. J Clin Endocrinol Metab 1996;81:2976–2979.
10.
Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C: HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000;95:1406–1412.
11.
Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel JP, Isaacson PG, Meignin V: High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002;99:2331–2336.
12.
Direkze S, Laman H: Regulation of growth signalling and cell cycle by Kaposi’s sarcoma-associated herpesvirus genes. Int J Exp Pathol 2004;85:305–319.
13.
Nitta Y: Case of malignant lymphoma associated with primary systemic plasmacytosis with polyclonal hypergammaglobulinemia. Am J Dermatopathol 1997;19:289–293.
14.
Weisenburger DD, Nathwani BN, Winberg CD, Rappaport H: Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol 1985;16:162–172.
15.
Hafner C, Hohenleutner U, Babilas P, Landthaler M, Vogt T: Targeting T-cells to hit B-cells: successful treatment of cutaneous plasmacytosis with topical pimecrolimus. Dermatology 2006;213:163–165.
16.
Shimizu S, Tanaka M, Shimizu H, Han-yaku H: Is cutaneous plasmacytosis a distinct clinical entity? J Am Acad Dermatol 1997;36:876–880.
17.
Carey WP, Rico MJ, Nierodzik M, Sidhu G: Systemic plasmacytosis with cutaneous manifestations in a white man: successful therapy with cyclophosphamide/prednisone. J Am Acad Dermatol 1998;38:629–631.
18.
Amin HM, McLaughlin P, Rutherford CJ, Abruzzo LV, Jones D: Cutaneous and systemic plasmacytosis in a patient of Asian descent living in the United States. Am J Dermatopathol 2002;24:241–245.
19.
Kimura K, Fujita H, Ishihama S: A case of cutaneous plasmacytosis (in Japanese). Hifu Rinsyo 1983;25:1045–1050.
20.
Lopez-Estebaranz JL, Rodriguez-Peralto JL, Ortiz Romero PL, Vanaclocha F, Iglesias Diez L: Cutaneous plasmacytosis: report of a case in a white man. J Am Acad Dermatol 1994;31:897–900.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.